January

January 19, 2015

MiRNA-based therapy for p53-mutated human tumors: MiRNA-760 promotes the tumor suppressor function of TAp73, premature senescence and inhibits the expression of cancer stem cell genes via down regulation of its target gene, 19/January/20145, 8.47 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based therapy for p53-mutated human tumors: MiRNA-760 promotes the tumor suppressor function of TAp73, premature senescence, and […]
January 19, 2015

Molecular therapy for Pulmonary Hypertension: Snail inhibits pulmonary hypertension via down regulation of its target gene, 19/January/2015, 8.04 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Molecular therapy for Pulmonary Hypertension: Snail inhibits pulmonary hypertension via down regulation of its target gene, 19/January/2015, […]
January 18, 2015

MiRNA-based therapy for Human cancer: miRNA-5481 increases the expression of tumor suppressor p53 via down regulation of its target gene, 18/January/2015, 23.32

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based therapy for Human cancer: miRNA-5481 increases the expression of tumor suppressor p53 via down regulation of […]
January 18, 2015

AntagomiR-based therapy for Metabolic diseases: MiRNA-224 suppresses the expression of MED13 and promotes insulin resistance and weight gain via up regulation of its target gene, 18/January/20145, 23.20

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, AntagomiR-based therapy for Metabolic diseases: MiRNA-224 suppresses the expression of MED13 and promotes insulin resistance and weight […]